Matches in Wikidata for { <http://www.wikidata.org/entity/Q65472920> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q65472920 description "clinical trial" @default.
- Q65472920 description "ensayu clínicu" @default.
- Q65472920 description "klinisch onderzoek" @default.
- Q65472920 description "клінічне випробування" @default.
- Q65472920 description "կլինիկական փորձարկում" @default.
- Q65472920 name "Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement" @default.
- Q65472920 name "Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement" @default.
- Q65472920 type Item @default.
- Q65472920 label "Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement" @default.
- Q65472920 label "Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement" @default.
- Q65472920 prefLabel "Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement" @default.
- Q65472920 prefLabel "Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement" @default.
- Q65472920 P1050 Q65472920-C100B600-6831-49CA-B94F-463F40D163F2 @default.
- Q65472920 P1132 Q65472920-29F24EAF-1D73-4D87-8DD4-ADE8005B326A @default.
- Q65472920 P1476 Q65472920-27430903-4B6D-43A7-8CFF-C61E36824F06 @default.
- Q65472920 P17 Q65472920-08D00632-F986-4DF2-9C4A-630A7FD589AA @default.
- Q65472920 P17 Q65472920-25403B36-94EF-4C3B-A7DC-1D211F391F6F @default.
- Q65472920 P17 Q65472920-872D2C9A-A35D-482D-A6D9-BCB6E7805981 @default.
- Q65472920 P17 Q65472920-8C29DA09-250A-40B9-B417-E24AD92450BA @default.
- Q65472920 P17 Q65472920-984BB415-D530-4CAF-AA47-334518AD1FAC @default.
- Q65472920 P17 Q65472920-B705B875-3AB6-49F3-B6BD-897539CC8D33 @default.
- Q65472920 P17 Q65472920-BE4770C5-5402-4D27-9D4A-7DEB8949988E @default.
- Q65472920 P1813 Q65472920-6E2B22FD-7122-4B23-A60A-BBD14017906F @default.
- Q65472920 P2899 Q65472920-CEF0FC66-ABEE-4D81-AB42-94A6C05DEA61 @default.
- Q65472920 P3098 Q65472920-E5D29A5F-256A-4E22-A5A1-EC94ADABED8E @default.
- Q65472920 P31 Q65472920-45650FDB-5171-416F-999C-8075D5155B0A @default.
- Q65472920 P4844 Q65472920-EBC8FF84-D759-44BF-985A-28FD383252BB @default.
- Q65472920 P580 Q65472920-EC3C7C71-C6F0-4EF2-99B4-5DA16EC0B03F @default.
- Q65472920 P582 Q65472920-39750E32-77CF-4D40-BD3F-4A069C3F299E @default.
- Q65472920 P6099 Q65472920-353BDAD8-0B77-49D0-A291-96BDEB610F15 @default.
- Q65472920 P8363 Q65472920-3460DA46-A43F-44D6-8C85-FDF5A3EE884D @default.
- Q65472920 P1050 Q9397786 @default.
- Q65472920 P1132 "+367" @default.
- Q65472920 P1476 "Factor Xa Inhibitor YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement: A Randomized, Enoxaparin-controlled, Open Label, Dose-escalation Study" @default.
- Q65472920 P17 Q17 @default.
- Q65472920 P17 Q252 @default.
- Q65472920 P17 Q334 @default.
- Q65472920 P17 Q833 @default.
- Q65472920 P17 Q865 @default.
- Q65472920 P17 Q869 @default.
- Q65472920 P17 Q928 @default.
- Q65472920 P1813 "PEARL-1" @default.
- Q65472920 P2899 "+18" @default.
- Q65472920 P3098 "NCT00408239" @default.
- Q65472920 P31 Q30612 @default.
- Q65472920 P4844 Q5222570 @default.
- Q65472920 P580 "2006-12-01T00:00:00Z" @default.
- Q65472920 P582 "2009-03-01T00:00:00Z" @default.
- Q65472920 P6099 Q42824440 @default.
- Q65472920 P8363 Q78089383 @default.